[HTML][HTML] Metabolic syndrome: updates on pathophysiology and management in 2021
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, MB Zerdan… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, MB Zerdan, S Allam… - International Journal of …, 2022 - cir.nii.ac.jp
抄録< jats: p> Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations
including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension …
including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension …
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, MB Zerdan, S Allam, MB Zerdan… - 2022 - agris.fao.org
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
[PDF][PDF] Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, M Bou Zerdan, S Allam… - Int. J. Mol …, 2022 - pdfs.semanticscholar.org
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
[HTML][HTML] Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, MB Zerdan, S Allam… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
G Fahed, L Aoun, S Allam, Y Bouferraa… - International Journal of …, 2022 - europepmc.org
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, M Bou Zerdan, S Allam… - 2022 - scholarhub.balamand.edu.lb
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
G Fahed, L Aoun, M Bou Zerdan… - International …, 2022 - search.ebscohost.com
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
[PDF][PDF] Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
G Fahed, L Aoun, M Bou Zerdan, S Allam… - Int. J. Mol …, 2022 - researchgate.net
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …